Koninklijke Philips PHG
NYSE PHG
$27.74 +0.12 (+0.43%)
At close: Aug 20, 2026 · 11:14 AM UTC

Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026)

Koninklijke Philips (PHG) posted quarterly Total Non-Current Liabilities of $9.1 billion for Q2 2026, down 8.64% year-over-year from $9.9 billion in Q2 2025, and down 7.96% quarter-over-quarter from $9.9 billion in Q1 2026.

Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.1 billion for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities fell 8.64% year-over-year to $9.1 billion; the TTM figure through Jun 2026 stood at $9.1 billion (down 8.64% YoY), while the FY2025 annual figure was $9.8 billion, up 4.7% from the prior year.
  • Total Non-Current Liabilities for Q2 2026 stood at $9.1 billion, down from $9.9 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $10.2 billion in Q3 2025, with the low at $9.1 billion in Q2 2026.
  • The 5-year median for Total Non-Current Liabilities is $9.8 billion (2023), against an average of $9.7 billion.
  • Peak annual rise in Total Non-Current Liabilities reached 7.89% in 2026, while the deepest fall reached 8.64% in 2026.
  • Koninklijke Philips' Total Non-Current Liabilities stood at $9.7 billion in 2022, then climbed by 0.86% to $9.7 billion in 2023, then retreated by 3.65% to $9.4 billion in 2024, then gained by 4.7% to $9.8 billion in 2025, then retreated by 7.75% to $9.1 billion in 2026.
  • Business Quant data shows PHG's Total Non-Current Liabilities at $9.1 billion in Q2 2026, $9.9 billion in Q1 2026, and $9.8 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 21.28 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 9.07 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 3.44 Bn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn 9.53 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.07 Bn
Mar 31, 2026 9.85 Bn
Dec 31, 2025 9.83 Bn
Sep 30, 2025 10.20 Bn
Jun 30, 2025 9.93 Bn
Mar 31, 2025 9.13 Bn
Dec 31, 2024 9.39 Bn
Jun 30, 2024 9.47 Bn
Dec 31, 2023 9.75 Bn
Jun 30, 2023 10.10 Bn
Dec 31, 2022 9.66 Bn
Jun 30, 2022 9.92 Bn
Dec 31, 2021 10.34 Bn
Jun 30, 2021 9.93 Bn
Dec 31, 2020 9.63 Bn
Jun 30, 2020 9.93 Bn
Dec 31, 2019 8.21 Bn
Jun 30, 2019 8.19 Bn
Dec 31, 2018 6.80 Bn
Jun 30, 2018 7.16 Bn